Teva Pharmaceutical Industries Ltd (TEVA)

Tel Aviv


Symbol		Exchange		Currency
TEVA	·	Tel Aviv	·	ILS	Delayed
TEVA	·	NYSE	·	USD	Real-time
TEVAN	·	Mexico	·	MXN	Delayed
TEVAy	·	TradeGate	·	EUR	Delayed
T1EV34	·	B3	·	BRL	Delayed
TEVAg	·	Vienna	·	EUR	Real-time

Currency in ILS

TEVA Pro Research

10,290

-90(-0.87%)

Closed·01/05

Fair Value

Unlock Value

Day's Range

10,260

10,370

52 wk Range

5,305

11,350

TEVA Income Statement

Assess the Teva income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the TEVA net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

15,878

14,925

15,846

16,544

17,258

Total Revenues Growth

aa.aa

-4.69%

-6%

+6.17%

+4.4%

+4.32%

Cost Of Revenues

aa.aa

8,284

7,952

8,200

8,481

8,320

Gross Profit

aa.aa

7,594

6,973

7,646

8,063

8,938

Gross Profit Growth

aa.aa

-1.71%

-8.18%

+9.65%

+5.45%

+10.85%

Gross Profit Margin %

aa.aa

47.83%

46.72%

48.25%

48.74%

51.79%

Other Operating Expenses, Total

aa.aa

4,515

4,311

4,461

4,690

4,986

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-3.34%	-4.52%	+3.48%	+5.13%	+6.31%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	967	838	953	998	1,013
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3,528	3,445	3,498	3,702	3,973
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	20	28	10	-10	0

Operating Income

aa.aa

3,079

2,662

3,185

3,373

3,952

Operating Income Growth

aa.aa

+0.79%

-13.54%

+19.65%

+5.9%

+17.17%

EBIT Margin %

aa.aa

19.39%

17.84%

20.1%

20.39%

22.9%

Net Interest Expenses

aa.aa

-891

-920

-961

-916

-824

Net Interest Expenses Growth

aa.aa

-11.79%

-3.25%

-4.46%

+4.68%

+10.04%

Interest Expense, Total

aa.aa

-891

-930

-1,029

-1,002

-916

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-67

-25

-94

-64

-97

EBT, Excl. Unusual Items

aa.aa

2,121

1,717

2,130

2,393

3,031

Gain (Loss) On Sale Of Assets

aa.aa

-20

Other Unusual Items, Total

aa.aa

-1,289

-2,732

-1,969

-2,339

-1,549

EBT, Incl. Unusual Items

aa.aa

667

-3,142

-622

-1,283

1,237

EBT, Incl. Unusual Items Growth

aa.aa

+115.63%

-571.06%

+80.2%

-106.27%

+196.41%

EBT, Incl. Unusual Items Margin

aa.aa

4.2%

-21.05%

-3.93%

-7.76%

7.17%

Income Tax Expense

aa.aa

211

-643

-7

676

-180

Net Income to Company

aa.aa

456

-2,499

-615

-1,959

1,417

Minority Interest

aa.aa

-39

320

-7

Net Income

aa.aa

417

-2,446

-559

-1,639

1,410

Net Income Growth

aa.aa

+110.45%

-686.57%

+77.15%

-193.2%

+186.03%

Net Income Margin %

aa.aa

2.63%

-16.39%

-3.53%

-9.91%

8.17%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

417

-2,446

-559

-1,639

1,410

Basic EPS - Continuing Operations

aa.aa

0.38

-2.2

-0.5

-1.45

1.23

Basic EPS - Continuing Operations Growth

aa.aa

+110.38%

-682.34%

+77.33%

-190.09%

+184.98%

Diluted EPS - Continuing Operations

aa.aa

0.38

-2.2

-0.5

-1.45

1.21

Diluted EPS - Continuing Operations Growth

aa.aa

+110.38%

-682.34%

+77.31%

-190%

+183.45%

Basic Weighted Average Shares Outstanding

aa.aa

1,102

1,110

1,119

1,131

1,145

Diluted Weighted Average Shares Outstanding

aa.aa

1,107

1,110

1,119

1,131

1,163

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

4,409

3,970

4,338

4,432

4,954

EBITDA Growth

aa.aa

-4.4%

-9.96%

+9.27%

+2.17%

+11.78%

EBITDA Margin %

aa.aa

27.77%

26.6%

27.38%

26.79%

28.71%

EBIT

aa.aa

3,079

2,662

3,185

3,373

3,952

* In Millions of USD (except for per share items)

FAQ

What was Teva’s revenue at year end?

At the end of the last reported fiscal year, Teva (TEVA) recorded total revenue of 17,258 million USD.

How much revenue did Teva report in the most recent quarter?

In its most recent quarterly earnings report, Teva posted revenue of 3,982 million USD.

What was Teva’s net income for the year?

For the full year, Teva reported net income of 1,410 million USD.

How much net income did Teva post in the last quarter?

In the most recent quarter, Teva (TEVA) posted net income of 369 million USD.

What was Teva’s gross profit for the year?

Gross profit for the year was reported at 8,938 million USD.

How much gross profit did Teva generate last quarter?

Teva recorded gross profit of 1,971 million USD in its latest quarterly report.

What was Teva’s annual operating income?

For the full year, Teva (TEVA) reported operating income of 3,952 million USD.

What was Teva’s operating income last quarter?

Quarterly operating income was 758 million USD.

What was Teva’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 997 million USD.

What was the quarter-over-quarter change in EBITDA for Teva?

EBITDA changed by -35% million USD compared to the last quarter.

What is Teva’s most recent gross profit margin?

The latest reported gross profit margin for Teva (TEVA) is 49% million USD.

What is Teva’s most recent net income margin?

Net income margin based on recent financials is 9% million USD.

What is Teva’s most recent EBIT margin?

Teva reported an EBIT margin of 19% million USD based on current figures.

How did Teva’s revenue change compared to the previous quarter?

Revenue changed by -15% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Teva?

In the latest quarter, gross profit changed by -26% million USD from the previous quarter.

S&P/TSX

33,891.18

-73.15

-0.22%

S&P/TSX 60

1,977.80

-4.92

-0.25%

US 30

49,454.30

-197.6

-0.40%

US 500

7,219.80

+10.8

+0.15%

S&P 500 VIX

16.99

+0.10

+0.59%

DAX

24,292.38

+337.82

+1.41%

Dollar Index

98.01

+0.090

+0.09%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	63.88	-1.48%	9.01M
TC Energy	90.63	-0.49%	4.98M
Toronto Dominion Bank	145.84	-0.33%	4.70M
Bank of Nova Scotia	106.05	+0.35%	4.24M
Bank of Montreal	207.41	+0.28%	2.07M
RBC	244.20	-0.05%	1.51M
Fairfax Financial	2,170.28	-7.67%	168.83K

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Vertiqal Studios	0.01	+200.00%	146.72K
Vertiqal Studios	0.01	+200.00%	146.72K
Irwin Naturals	0.30	+150.00%	3.24K
Taurus Gold	0.07	+150.00%	46.05K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Noveris Health Sciences	0.80	-57.67%	46.86K
Noveris Health Sciences	0.800	-57.67%	46.86K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	17.07	+0.35%	4.16M
Air Canada	18.26	-2.09%	5.48M
Celestica Inc.	569.51	+2.12%	347.49K
Toronto Dominion Bank	145.84	-0.33%	4.70M
Canadian Natural	63.88	-1.48%	9.01M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A A Aaaaa A	90.41	+62.25%	146.69
Aaa Aaaaaaaaaaaaa	5.35	+61.22%	8.63
Aaaaaaaaaaaaa A Aaaa	3.20	+58.61%	5.08
Aaaaaaaa	7.67	+52.08%	11.66
Aaa A Aa	2,441.95	+46.09%	3,567.44
Aaa Aaaaaaaaaa	11.26	+42.62%	16.06
Aaa Aa Aaaaaaa A	10.80	+41.35%	15.27

Name	Last	Upside	Fair Value
A A Aaaaa A	90.41	+62.25%	146.69
Aaa Aaaaaaaaaaaaa	5.35	+61.22%	8.63
Aaaaaaaaaaaaa A Aaaa	3.20	+58.61%	5.08
Aaaaaaaa	7.67	+52.08%	11.66
Aaa A Aa	2,441.95	+46.09%	3,567.44
Aaa Aaaaaaaaaa	11.26	+42.62%	16.06
Aaa Aa Aaaaaaa A	10.80	+41.35%	15.27

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Teva Pharmaceutical Industries Ltd (TEVA)

TEVA Income Statement

FAQ

What was Teva’s revenue at year end?

How much revenue did Teva report in the most recent quarter?

What was Teva’s net income for the year?

How much net income did Teva post in the last quarter?

What was Teva’s gross profit for the year?

How much gross profit did Teva generate last quarter?

What was Teva’s annual operating income?

What was Teva’s operating income last quarter?

What was Teva’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Teva?

What is Teva’s most recent gross profit margin?

What is Teva’s most recent net income margin?

What is Teva’s most recent EBIT margin?

How did Teva’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Teva?

Trending Stocks